![](https://webarchive.library.unt.edu/eot2008/20090119111213im_/http://www.fda.gov/cder/templates/graphics/dot_clear.gif) |
Basiliximab
Product Approval Information - Licensing Action
Proper name: Basiliximab
Tradename: Simulect
Manufacturer: Novartis Pharmaceutical Corp, East Hanover, NJ, License #1244
Indication for Use: Include the addition of a new single dose 10mg strength of drug product
Approval Date: 1/2/2003
Type of submission: Biologics license application supplement
Approval Letter
(Text)
Label (PDF),
(Text)
Last Updated: 2/4/2003
Back
to Top
Back to Index
Date created: September 16, 2003 |
![](https://webarchive.library.unt.edu/eot2008/20090119111213im_/http://www.fda.gov/cder/templates/graphics/dot_clear.gif) |